Click it and Unblock the Notifications
For Quick Alerts
For Daily Alerts
Just In
Don't Miss
-
2024 Jeep Wrangler Facelift Video Review: Off-Roading Specialist Gets More Friendly -
Chacha Vidhayak Hain Humare 3 OTT Release Date & Platform: 5 Reasons To Watch Zakir Khan’s Show -
UPSC CAPF 2024 registration begins; Apply online for 506 Assistant Commandant posts, Know more -
Honeywell Trueno U5100 Review: Quality Audio Meets Comfortable Design at an Oh-So Reasonable Price -
103 Not Out: S Ramdas - 103-year-old CSK fan fondly called 'Senior Valiban' - aspires to meet MS Dhoni -
Rs 44,000 Crore M-Cap Lost, Stock Falls 10%, No More 4th Largest Bank; How RBI's Ban Rocked Kotak -
Exclusive: On World Malaria Day 2024, Dr Shares Danger Signs Parents Must Watch Out For In Child With Malaria -
Escape to Kalimpong, Gangtok, and Darjeeling with IRCTC's Tour Package; Check Itinerary
Covaxin for children likely to be available by September says AIIMS Director Dr Randeep Guleria
New Delhi, July 24: All India Institute of Medical Sciences (AIIMS) Director Dr Randeep Guleria on Saturday said that Bharat Biotech's Covaxin trials for children are presently underway and the results are expected to be released by September.
Recommended Video
Covid
vaccine
for
children
likely
by
September,
says
AIIMS
chief
|
Oneindia
News
This statement by the AIIMS Chief comes even as India is yet to clear a Covid-19 vaccine for children.
On Friday, the European medicines watchdog approved the use of Moderna's coronavirus vaccine for children aged 12 to 17. In May, the United States had authorized the Pfizer-BioNTech Covid-19 vaccine for children aged 12 to 15 years old.
